Status:
COMPLETED
Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a pilot that will evaluate two regimens for treating HIV infected patients that haven't been on treatment before. HIV/AIDS patients may have an increased risk of myocardial infarction and anti...
Detailed Description
We will check blood studies used to evaluate HIV patients response to therapy including CD4 count and HIV viral load test. We will check routine safety labs done on HIV patients and also check homocys...
Eligibility Criteria
Inclusion
- Patients must be HIV-1 positive and naïve to HIV therapy.
- Patients must plan to participate and be available for the trial for the 96-week study period.
- Patients followed at Thomas Street Clinic.
- Patients must be over 18 years old.
Exclusion
- Patients must not be pregnant or plan to become pregnant over the 96-week study period.
- Patients cannot be on a proton pump inhibitor.
- Patients cannot be undergoing treatment for active tuberculosis.
- Renal Insufficiency with a creatinine clearance \< 50 ml/min/1.73 m2 by the MDRD GFR calculation.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00762892
Start Date
January 1 2009
End Date
January 1 2013
Last Update
January 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Street Clinic
Houston, Texas, United States, 77009